Bank of Montreal’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-6,026
Closed -$465K 4341
2015
Q4
$465K Hold
6,026
﹤0.01% 2024
2015
Q3
$496K Hold
6,026
﹤0.01% 1856
2015
Q2
$531K Hold
6,026
﹤0.01% 1939
2015
Q1
$532K Buy
+6,026
New +$535K ﹤0.01% 1899

Other funds holding NVS

Bank of Montreal's NVS Position: Q2 2026 in Review

Bank of Montreal reduced its Novartis (NVS) stake by 60% in Q2 2026, selling an estimated $23.1M and leaving 104,932 shares worth $16.4M. The position accounts for 0.01% of the portfolio, ranked #996.

Bank of Montreal first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $136M in Q4 2025. 1,269 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Bank of Montreal held 104,932 shares of Novartis worth $16.4M as of Q2 2026.
  • Bank of Montreal sold 154,413 Novartis shares in Q2 2026, an estimated $23.1M.
  • Novartis made up 0.01% of Bank of Montreal's portfolio in Q2 2026, its #996 holding.
  • Bank of Montreal first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
  • Bank of Montreal's Novartis position peaked at $136M in Q4 2025.
  • 1,269 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.